Trillium Therapeutics

The top 10 biopharma M&A deals in 2021
Fierce Pharma
Tue, 01/18/22 - 10:53 am
M&A
CSL
Vifor
Jazz Pharmaeuticals
GW Pharma
Novo Nordisk
Dicerna
Horizon Therapeutics
Viela Bio
Perrigo
HRA Pharma
Sanofi
Kadmon
Merck
Acceleron
Pfizer
Arena Pharmaceuticals
Translate Bio
Trillium Therapeutics
Amgen
Five Prime Therapeutics
Pfizer acquires Trillium Therapeutics for $2.22bn
Pharmaceutical Business Review
Thu, 11/18/21 - 10:32 am
Pfizer
Trillium Therapeutics
M&A
immuno-oncology
Pfizer and Trillium: How a $25M investment led to a $2.3B buyout
Fierce Biotech
Tue, 09/14/21 - 10:52 am
Pfizer
Trillium Therapeutics
M&A
Here's the Biotech Pfizer Should Consider Acquiring Next
Motley Fool
Fri, 09/3/21 - 11:00 am
Pfizer
MRNA
vaccines
BioNTech
Trillium Therapeutics
Gritstone Bio
Pfizer deal a spark for M&A, or just fuel for an empty pipeline? Analysts try to read the tea leaves
Fierce Biotech
Tue, 08/24/21 - 11:01 am
Pfizer
Trillium Therapeutics
M&A
Pfizer to acquire immuno-oncology company Trillium
Biopharma Reporter
Mon, 08/23/21 - 11:59 am
Pfizer
Trillium Therapeutics
M&A
immuno-oncology
Trillium unveils CD47 clinical research priorities as investors await solid tumor data
Fierce Biotech
Wed, 04/28/21 - 10:52 am
Trillium Therapeutics
CD47
solid tumors
oncology
cancer
The biotech resurrection continues
EP Vantage
Fri, 01/15/21 - 10:39 am
biotech
Lexicon Pharmaceuticals
DBV Technologies
Pfizer
Trillium Therapeutics
Pfizer invests $120M in 4 biotechs through new growth fund
Fierce Biotech
Tue, 01/12/21 - 10:56 am
Pfizer
funding
PBGI
Homology Medicines
Essa Pharma
Vedanta Biosciences
Trillium Therapeutics
Red-Hot Biotechs to Take Spotlight at Blood Disorder Meeting
Yahoo/Bloomberg
Fri, 12/4/20 - 11:09 am
ASH2020
Trillium Therapeutics
CRISPR Therapeutics
Fate Therapeutics
Vertex Pharmaceuticals
Trillium Therapeutics Doses First Patient With Checkpoint Inhibitor TTI-622
CP Wire
Thu, 06/14/18 - 10:11 am
Trillium Therapeutics
TTI-622
cancer immunotherapies
Trillium Therapeutics Doses First Patient With Checkpoint Inhibitor TTI-622
Thu, 06/14/18 - 10:07 am
Trillium Therapeutics
TTI-622
cancer immunotherapies